Boosters: the immunological equivalent of heroin addiction – expert research bioscientist Dr David Wiseman

Loading player...
Though the uptake of COVID-19 boosters remains low in South Africa, with a mere 3.6 million booster shots reportedly administered by August, the South African Government and international health authorities continue to urge citizens to join the conga line of “responsible” people queuing to get boosted. Given the significantly high seroprevalence of SARS-CoV-2 antibodies among the South African population, there is no justification for boosters, even less the FDA’s Emergency Use Authorisation thereof. In this long-form interview with Dr David Wiseman, a PhD research bioscientist with a background in pharmacy, pharmacology and immunology, the significant risks associated with continued boosting were meticulously examined. Wiseman’s ability to simplify technical knowledge and his explanation of the dangers associated with boosters were second to none. According to Wiseman, attempting to boost our way out of the pandemic is the immunological equivalent of heroin addiction. Wiseman furthermore provided critical insight into the FDA and CDC’s egregious abandonment of once well-established standards, evidenced by the EUA issued for the new untested BA4/5 bivalent boosters. Note that Wiseman referred to several slides during the interview which have been embedded in the article on BizNews.com. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Nov 2022 1AM English South Africa Investing · Business News

Other recent episodes

The BizNews Edge: Nedbank, Grindrod and the coal stock no one was watching

Nedbank confirmed its guidance this morning, and its East Africa deal is weeks from closing - a transformation most investors are still underpricing. Grindrod's Port of Maputo posted extraordinary volumes, but the share may already be priced for perfection. A small coal miner no one follows just disclosed an 1,800%…
24 Jun 8AM 26 min

The BizNews Edge: Economic warnings flash; Corporate giants mispriced; SpaceX tumbles

We explore a toughening economic climate as South African consumer confidence drops and central bank indicators flash red. Discover why the market is blindly punishing value, dragging down Sibanye Stillwater’s debt-free gold business despite solid restructuring plans. We also highlight Attacq’s resilient property portfolio and Steenkamp Kraal’s historic rare earth…
23 Jun 6AM 13 min